OETC

The Oxford Emergent Tuberculosis Consortium (OETC) is a joint venture between the University of Oxford and Emergent BioSolutions to further develop MVA85A with funding from Wellcome Trust, and Aeras Global TB Vaccine Foundation.

ANNOUNCEMENTS

Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vaccine with Funding from Wellcome Trust and Aeras Global TB Vaccine Foundation

OETC Endeavor to End Tuberculosis (video 4:34)